Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Life after liver surgery: new study tracks Patients' Real-World recovery

NCT ID NCT02399995

Knowledge-focused Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 219 patients who had liver surgery for colorectal cancer that spread to the liver. Researchers track how patients' quality of life changes over time using surveys. The goal is to help doctors and patients understand what to expect after surgery, so patients can make better treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

219 people

The number who actually took part.

Started

Mar 2015

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients scheduled to undergo liver resection who meet the established criteria will be approached for participation in this study during their preoperative visit. Should patients not undergo their liver resection surgery within 30 days of consent they will be excluded and replaced. Patients undergoing a two stage resection will have their time point frozen for up to six months after their initial surgery. If the time before the second stage of their resection exceeds six months, these patients will be excluded and replaced. The time point will restart at the completion of the second time point. If the patient has an incomplete resection without mention of a second stage resection, the patient will be made ineligible, taken off study, and replaced.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of Colorectal cancer liver metastases (CRLM) * \> 18 years of age * Absence of unresectable extrahepatic disease * No previous liver surgery for CRLM * Clinical risk score (CRS) \>/= 3 or \> 4 tumors * CRS includes the following variables; * Lymph node positive primary * Disease free interval \<12 months * CEA level \>200ng/mL (highest CEA level within 6 months prior to surgery, not including day of surgery) * Tumor size \> 5cm * Number of tumors \>1(based on most recent scan or pathology before liver resection) * Each variable is given a score of one and summed to give final CRS * Clinical risk score (CRS) \< 3 with pending variables that cannot be determined preoperatively * If CRS is still \< 3 postoperatively, these patients will be excluded and replaced (inevaluable). * Ability to read and write in English * Undergoing liver resection/ ablation for CRLM * Underwent liver resection/ ablation for CRLM, but not their primary tumors Exclusion Criteria: * Non-English speaking * Inability to read and/or write * International Patients * Concurrent malignancy (excluding non-melanoma skin cancers)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal liver metastasis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal liver metastasis

Contacts and locations

Locations

  • Memorial Sloan Kettering Basking Ridge (Consent and Follow up)

    Basking Ridge, New Jersey, United States

  • Memorial Sloan Kettering Bergen (Consent and Follow up)

    Montvale, New Jersey, 07645, United States

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York, 10065, United States

  • Memorial Sloan Kettering Commack (Consent and Follow up)

    Commack, New York, 11725, United States

  • Memorial Sloan Kettering Monmouth (Consent and Follow up)

    Middletown, New Jersey, 07748, United States

  • Memorial Sloan Kettering Nassau (Consent and follow up)

    Uniondale, New York, 11553, United States

  • Memorial Sloan Kettering Westchester (Consent and Follow Up)

    Harrison, New York, 10604, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.